BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33488010)

  • 1. A Foldable Nonpenetrating Keratoprosthesis: Medium to Long-Term Clinical Results in Patients with Corneal Blindness due to Noninflammatory Anterior Cornea Disease.
    Vargas JM; Shiuey E
    Middle East Afr J Ophthalmol; 2020; 27(3):150-155. PubMed ID: 33488010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KeraKlear Artificial Cornea Implantation Assisted by Femtosecond Laser in Eyes With Aniridia.
    de Farias CC; Bezerra FM; Lamazales LL; Nosé W; Pereira Gomes JÁ
    Cornea; 2022 May; 41(5):635-639. PubMed ID: 35383618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.
    Alió JL; Mulet ME; Haroun H; Merayo J; Ruiz Moreno JM
    Br J Ophthalmol; 2004 Dec; 88(12):1585-9. PubMed ID: 15550368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Keratoprostheses: Last Hope for the Most Severe Corneal Diseases].
    Bachmann B; Schaub F; Cursiefen C
    Klin Monbl Augenheilkd; 2022 Sep; 239(9):1165-1179. PubMed ID: 35970191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new epidescemetic keratoprosthesis: pilot investigation and proof of concept of a new alternative solution for corneal blindness.
    Alio JL; Abdelghany AA; Abu-Mustafa SK; Zein G
    Br J Ophthalmol; 2015 Nov; 99(11):1483-7. PubMed ID: 25868791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
    Aoun T; Harissi-Dagher M
    J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of the MICOF keratoprosthesis surgery.
    Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
    Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Meta-Analysis of the Medium- and Long-Term Outcomes of the Boston Type 1 Keratoprosthesis.
    Priddy J; Bardan AS; Tawfik HS; Liu C
    Cornea; 2019 Nov; 38(11):1465-1473. PubMed ID: 31403526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.
    Bakshi SK; Graney J; Paschalis EI; Agarwal S; Basu S; Iyer G; Liu C; Srinivasan B; Chodosh J
    Cornea; 2020 Apr; 39(4):484-490. PubMed ID: 31724985
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.